Cargando…

Real-world cost-effectiveness of targeted therapy in metastatic renal cell carcinoma in Sweden: a population-based retrospective analysis

OBJECTIVE: To explore cost-effectiveness of targeted therapies (TTs) in the treatment of metastatic renal cell carcinoma (mRCC) in a real-world context using a nationwide population-based approach. METHODS: Data on patients diagnosed with mRCC between 2002 and 2012 were extracted from Swedish nation...

Descripción completa

Detalles Bibliográficos
Autores principales:	Redig, Josefine, Dalén, Johan, Harmenberg, Ulrika, Lindskog, Magnus, Ljungberg, Börje, Lundstam, Sven, Sandin, Rickard, Wahlgren, Thomas, Åkerborg, Örjan, Jakobsson, Maria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6371932/ https://www.ncbi.nlm.nih.gov/pubmed/30799955 http://dx.doi.org/10.2147/CMAR.S188849

Ejemplares similares

Cancer Characteristics and Current Treatments of Patients with Renal Cell Carcinoma in Sweden
por: Thorstenson, Andreas, et al.
Publicado: (2015)

Clinical T1a Renal Cell Carcinoma, Not Always a Harmless Disease—A National Register Study
por: Almdalal, Tarik, et al.
Publicado: (2022)

Treatment and overall survival in renal cell carcinoma: a Swedish population-based study (2000–2008)
por: Wahlgren, T, et al.
Publicado: (2013)

Socioeconomic cost of AML in Sweden—A population‐based study using multiple nation‐wide registers
por: Hernlund, Emma, et al.
Publicado: (2021)

Progress in survival in renal cell carcinoma through 50 years evaluated in Finland and Sweden
por: Hemminki, Kari, et al.
Publicado: (2021)

Survival in bladder and upper urinary tract cancers in Finland and Sweden through 50 years
por: Hemminki, Kari, et al.
Publicado: (2022)

The cost-effectiveness of growth hormone replacement therapy (Genotropin®) in hypopituitary adults in Sweden
por: Bolin, Kristian, et al.
Publicado: (2013)

Epidemiology of firearm injuries in Sweden
por: Nyberger, Karolina, et al.
Publicado: (2021)

Specific Genomic Aberrations Predict Survival, But Low Mutation Rate in Cancer Hot Spots, in Clear Cell Renal Cell Carcinoma
por: Köhn, Linda, et al.
Publicado: (2015)

Incidence trends in bladder and lung cancers between Denmark, Finland and Sweden may implicate oral tobacco (snuff/snus) as a possible risk factor
por: Hemminki, Kari, et al.
Publicado: (2021)

Interpreting overall survival results when progression-free survival benefits exist in today’s oncology landscape: a metastatic renal cell carcinoma case study
por: Tang, Yiyun, et al.
Publicado: (2014)

Birth-death prior on phylogeny and speed dating
por: Åkerborg, Örjan, et al.
Publicado: (2008)

Reduced number of CD169(+) macrophages in pre‐metastatic regional lymph nodes is associated with subsequent metastatic disease in an animal model and with poor outcome in prostate cancer patients
por: Strömvall, Kerstin, et al.
Publicado: (2017)

Perivascular Neuropilin‐1 expression is an independent marker of improved survival in renal cell carcinoma
por: Morin, Eric, et al.
Publicado: (2020)

Cost-effectiveness of dronedarone and standard of care compared with standard of care alone: US results of an ATHENA lifetime model
por: Reynolds, Matthew R, et al.
Publicado: (2013)

Plasma and Urine Free Glycosaminoglycans as Monitoring and Predictive Biomarkers in Metastatic Renal Cell Carcinoma: A Prospective Cohort Study
por: Gatto, Francesco, et al.
Publicado: (2023)

Telomere Length in Relation to Immunological Parameters in Patients with Renal Cell Carcinoma
por: Svenson, Ulrika, et al.
Publicado: (2013)

HiCapTools: a software suite for probe design and proximity detection for targeted chromosome conformation capture applications
por: Anil, Anandashankar, et al.
Publicado: (2018)

The cost impact of disease progression to metastatic castration-sensitive prostate cancer
por: Trinh, Quoc-Dien, et al.
Publicado: (2022)

Treatment pattern in patients with idiopathic membranous nephropathy—practices in Sweden at the start of the millennium
por: Lönnbro-Widgren, Jennie, et al.
Publicado: (2016)

DNA methylation associates with survival in non-metastatic clear cell renal cell carcinoma
por: Evelönn, Emma Andersson, et al.
Publicado: (2019)

Paternal use of antidepressants and offspring outcomes in Sweden: nationwide prospective cohort study
por: Viktorin, Alexander, et al.
Publicado: (2018)

Antidepressant effects of novel positive allosteric modulators of Trk-receptor mediated signaling – a potential therapeutic concept?
por: Madjid, Nather, et al.
Publicado: (2023)

Volumetric FDG-PET predicts overall and progression- free survival after 14 days of targeted therapy in metastatic renal cell carcinoma
por: Farnebo, Jacob, et al.
Publicado: (2014)

Ilixadencel, a Cell-based Immune Primer, plus Sunitinib Versus Sunitinib Alone in Metastatic Renal Cell Carcinoma: A Randomized Phase 2 Study
por: Lindskog, Magnus, et al.
Publicado: (2022)

Cost-Effectiveness Analysis of Sequential Biologic Therapy with Ixekizumab Versus Secukinumab in the Treatment of Active Psoriatic Arthritis with Concomitant Moderate-to-Severe Psoriasis in the UK
por: Schweikert, Bernd, et al.
Publicado: (2020)

Metagenomic Analysis from the Interior of a Speleothem in Tjuv-Ante's Cave, Northern Sweden
por: Zepeda Mendoza, Marie Lisandra, et al.
Publicado: (2016)

Physical Activity and Sports—Real Health Benefits: A Review with Insight into the Public Health of Sweden
por: Malm, Christer, et al.
Publicado: (2019)

Cancer risk in individuals with intellectual disability in Sweden: A population-based cohort study
por: Liu, Qianwei, et al.
Publicado: (2021)

Socio-Demographic and Geographical Factors in Esophageal and Gastric Cancer Mortality in Sweden
por: Ljung, Rickard, et al.
Publicado: (2013)

Spinal anaesthesia with clonidine: pain relief and earlier mobilisation after open nephrectomy – a randomised clinical trial
por: Thurm, Mascha, et al.
Publicado: (2022)

Perivascular PDGFR-β is an independent marker for prognosis in renal cell carcinoma
por: Frödin, Magnus, et al.
Publicado: (2017)

Systemic inflammatory syndromes as life-threatening side effects of immune checkpoint inhibitors: case report and systematic review of the literature
por: Liu, Lisa L, et al.
Publicado: (2023)

Bilateral versus Single Internal Mammary Coronary Artery Bypass Grafting in Sweden from 1997–2008
por: Dalén, Magnus, et al.
Publicado: (2014)

Predicting grey-sided vole occurrence in northern Sweden at multiple spatial scales
por: Magnusson, Magnus, et al.
Publicado: (2013)

How do people choose to be informed? A survey of the information searched for in the choice of primary care provider in Sweden
por: Hoffstedt, Caroline, et al.
Publicado: (2021)

Real-world Treatment Sequencing in Patients with Metastatic Castration-resistant Prostate Cancer: Results from the Prospective, International, Observational Prostate Cancer Registry
por: Bjartell, Anders, et al.
Publicado: (2022)

Child suicides in Sweden, 2000–2018
por: Junuzovic, Mensura, et al.
Publicado: (2021)

Phase I clinical trial of AXL1717 for treatment of relapsed malignant astrocytomas: analysis of dose and response
por: Aiken, Robert, et al.
Publicado: (2017)

Gene expression pattern of the epidermal growth factor receptor family and LRIG1 in renal cell carcinoma
por: Thomasson, Marcus, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_si77pl8pckg1goqqfu5p75ojdm